Oramed Pharmaceuticals
ORMP
#8960
Rank
C$0.19 B
Marketcap
C$4.77
Share price
-2.25%
Change (1 day)
42.27%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): C$1.13

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is C$1.11. In 2024 the company made an earnings per share (EPS) of C-$0.66 a decrease over its 2023 EPS that were of C$0.19.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$1.13-270.87%
2024C-$0.66-442.86%
2023C$0.19-114.89%
2022C-$1.2920.51%
2021C-$1.0739.29%
2020C-$0.77-31.71%
2019C-$1.13-4.65%
2018C-$1.188.86%
2017C-$1.09-9.2%
2016C-$1.2029.85%
2015C-$0.928.06%
2014C-$0.855.08%
2013C-$0.813.51%
2012C-$0.78137.5%
2011C-$0.33-60%
2010C-$0.83-0%
2009C-$0.83-16.67%
2008C-$0.99-25%
2007C-$1.32700%
2006C-$0.17303.56%
2005C-$0.04089

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
C$4.83 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
C$2.84 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
C-$8.17-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
C-$0.26-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
C-$0.41-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel